• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

S Dhanabalan is the whipping boy for the famiLee - slapped by LHL, now kicked out by HC

LITTLEREDDOT

Alfrescian (Inf)
Asset
Goh Chok Tong and S Dhanabalan are the #1 and #2 seat-warmers for the famiLee

Retiring Temasek CEO Ho Ching to join Temasek Trust board, take over as chairman from April 1, 2022​

Ms Ho Ching will be appointed to Temasek Trust’s board of directors with effect from Oct 1, 2021, and take over as chairman from April 1, 2022.


Ms Ho Ching will be appointed to Temasek Trust’s board of directors with effect from Oct 1, 2021, and take over as chairman from April 1, 2022.
ST PHOTO: KUA CHEE SIONG
chooyunting.png

Choo Yun Ting

Sep 30, 2021

SINGAPORE - Retiring Temasek Holdings chief executive Ho Ching will be taking over as chairman of Temasek Trust from April 1, 2022.
Ms Ho, 68, will be appointed to Temasek Trust's board of directors with effect from Friday (Oct 1), the same day she is retiring from the Singapore investment company.
From April 1, she succeeds Mr S Dhanabalan, who will remain on the board and be designated Chairman Emeritus.
In a separate statement on Thursday, Temasek also announced two new appointments to its board of directors.
Mastercard executive chairman Ajay Banga's appointment is effective Friday, while GGV Capital managing partner Jenny Lee will join the board on Jan 1, 2022.
Temasek said that the new appointments to its board continue a process of transition, following the recent retirement of director Goh Yew Lin and the retirements of Ms Ho and Mr Robert Ng on Oct 1.




eb-ajay-093021_2x.jpg
The appointments of Mr Ajay Banga (left) and Ms Jenny Lee will be effective from Oct 1, 2021 and Jan 1, 2022 respectively. PHOTOS: TEMASEK

Ms Ho is being succeeded by Mr Dilhan Pillay, who will hold a dual role as CEO of both Temasek and its commercial arm Temasek International.
At the same time, three new directors will be appointed to the board of Temasek Trust, which was established in 2007 to provide governance and financial oversight of the company's philanthropic endowments that fund the work of designated beneficiaries.
Its beneficiaries include Temasek Foundation and Temasek Life Sciences Laboratory.

The three new directors - Mr Benny Lim, Mr Teo Ming Kian and Mr Tow Heng Tan - will join the board with effect from Jan 1, 2022.
Mr Dhanabalan, who has been chairman of Temasek Trust since September 2015, said: "Ho Ching has a deep and passionate commitment to so many community causes, and has been instrumental in Temasek's own stewardship journey over the past two decades.
"The board decided we would ask her to join us, and to continue that commitment by leading Temasek Trust next year."
Ms Ho said she was honoured to be invited to join the board of Temasek Trust, and said she sees great opportunity for it to evolve its role given the scale it has reached.
"I am very impressed by the remarkable progress that Temasek Trust has made since its founding over 10 years ago.
"Temasek Trust has enabled a steady and sustainable support for Temasek Foundation and other initiatives to deliver vitally important programmes in the communities in Singapore and around Asia," she said.
She paid tribute to Mr Dhanabalan's work as chairman, noting how he helped to underline the importance of Temasek Trust's governance role.
"By getting that right, he has solidified Temasek Trust as a trusted partner and platform to deepen the interest for thoughtful and impactful philanthropy on a sustainable basis."
 
Last edited:

mojito

Alfrescian
Loyal
Aiya these kind of retirements is like lky retire to become senior minister mentor lah. Looong retire in to what u tell me? :rolleyes:
 

tanwahtiu

Alfrescian
Loyal
Wah... ahneh shines and a Superstar talents these days. Appoint for Indian market only siboh....

Their father used to be jagar for banks only, and now their children hold top posts in finance? Then what are we the non-Indians? We can lose to bayhi Singh in talent meh?

Fuck bastard Loong...
 

laksaboy

Alfrescian (Inf)
Asset
Retiring Temasek CEO Ho Ching to join Temasek Trust board, take over as chairman from April 1, 2022

See? Even within the cesspit of Temasek the 太上皇 system exists. Something like the senior minister mentor emeritus.
 

millim6868

Alfrescian
Loyal
when locals are old tell u Don ask for so much ,expect pay reduce, one even say want to eat hawker , restaurants , Don ask for so much but for themselves it's a different story ,all these clowns screw up so many ,still 61,% lagi, happy with them ,look at the waterplant,etc,all carrot
 

Peace Maker

Alfrescian
Loyal
It will be good idea for those above 62 years old to be completely retired from all their appointments whether in the public or private sector. For them, they can enjoy their golden years, play with their grand children (if any) or get a pet dog, go travel around the world after covid pandemic is over. There are a lot more meaningful things to do than clinging on to their position because of greed, worry loss of power, respect or prestige. They can also do volunteer work to improve the lives of those in poverty or sick. What you have done during your time is good enough, relax, let it go & let others have the chance to take the lead.
 

Hypocrite-The

Alfrescian
Loyal
Errr... , meaning , in the Food Chains , Leeches are Superior to Parasites ???
.

View attachment 124003

View attachment 124004
Leaches have benefits to human health. Parasites don't

How Leeches Can Save Lives And Limbs for Some Patients
March 23, 2020

medical leeches
Most people cringe at the mere mention of the word leeches. Even more would be alarmed at the thought of having them attached to their skin as part of their medical plan of care. And yet, in modern operating rooms across the country, that is exactly what is happening.

"Despite all the technical advances in modern medicine, in certain post-surgical situations, we do still rely on one of nature’s most primitive organisms – the leech – to assist us in achieving a good outcome,” says Rod Rezaee, MD, UH otolaryngologist and head and neck surgeon.

Leeches have been used medically for thousands of years – dating back to ancient Greece and Egypt when bloodletting was a common practice. Practitioners of the time believed the removal of blood from a patient could prevent illness and cure disease. Sometimes crude instruments were used for bloodletting but more often, leeches were used. Once attached to the patient’s skin, the leeches would do what they were designed to do – feed on blood.

Clearly, modern clinicians do not support the practice of bloodletting. However, many do believe the use of leeches in certain, very specific medical situations has the potential to save lives and limbs.

Preventing a Rare Complication After Surgery
Reattachment operations, skin grafts and reconstructive plastic surgeries for cancer and trauma often require microsurgical techniques – the use of a microscope and specialized instruments to attach tiny blood vessels with equally tiny sutures and needles. Although these procedures are successful up to 98 percent of the time, in rare cases a flap or reattached body part may develop a dangerous complication called venous congestion.

Venous congestion occurs when the tiny, thin-walled veins involved in microsurgical procedures are unable to carry the appropriate amount of blood away from the surgical site. Instead, the blood pools in the veins and is unable to flow back to the heart and lungs to be re-oxygenated. If the congestion is left untreated, carbon dioxide will accumulate in the stagnant blood and ultimately cause tissue death. This is when medicinal leech therapy may be recommended for an optimal outcome.

Keeping Blood Flowing
Leech saliva contains hirudin, an anticoagulant and anti-platelet agent that works to prevent blood clots and reduce the amount of congested blood in the tissues. Other chemicals in leech saliva keep the blood flowing in the damaged area, even after the leech is detached, allowing time for new veins to grow and the existing ones to widen and accommodate more blood flow. As a bonus, the treatment is painless – when the leech bites, they release a naturally occurring anesthetic that numbs the area.

Even though the use of leeches can prevent tissue death and promote healing in select cases, patients and families are often uneasy with the concept,” Dr. Rezaee says. “However, when we openly communicate with them about our goals and the reasons for the therapy, most patients understand and are accepting of the treatment."

The U.S. Food and Drug Administration in 2004 approved the use of leeches for localized venous congestion after surgery, recognizing them as living, breathing medical devices. Given that the scientific name for the leech is hirudinea, their use for medical purposes is often referred to as hirudotherapy.

Leeches are bred specifically for medical use at leech farms around the country. They are sanitized before attachment to the patient are are used only once. After they have fed and cropped off the patient, they are anesthetized and disposed of as medical waste.

Related links
University Hospitals Ear, Nose & Throat Institute provides complete otolaryngology care for children and adults. Our subspecialty areas focus on areas of the head and neck that may benefit from surgical intervention. Learn more about the UH Ear, Nose & Throat Institute.

Share
 
Top